U.S. Markets open in 5 hrs 17 mins

Citius Pharmaceuticals, Inc. (47N.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.9453+0.0105 (+1.12%)
As of 08:01AM CEST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9348
Bid0.9461 x N/A
Ask0.9726 x N/A
Day's Range0.9453 - 0.9453
52 Week Range0.7251 - 1.6798
Avg. Volume195
Market Cap141.54M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-0.3870
Earnings DateMay 10, 2023 - May 15, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • Simply Wall St.

    When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven?

    Citius Pharmaceuticals, Inc. ( NASDAQ:CTXR ) is possibly approaching a major achievement in its business, so we would...

  • PR Newswire

    Citius Pharmaceuticals Confirms No Exposure to Silicon Valley Bank

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) confirms that it does not hold any cash or maintain any accounts at Silicon Valley Bank (SVB), and has no current or prior business relationship with SVB.

  • PR Newswire

    Citius Pharmaceuticals to Participate in the 35th Annual Roth Conference

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in the 35th Annual Roth Conference being held March 12-14, 2023 in Dana Point, California. Citius Chairman and CEO Leonard Mazur will host one-on-one meetings with institutional investors and analysts on Monday, March 13th and Tuesday, March 14th.